The rise in geriatric population, bioresorbable vascular scaffolds, developments in interventional cardiology devices have resulted in boosting the Interventional Cardiology Devices market. 

The global interventional cardiology devices market is forecast to reach USD 26.71 Billion by 2028, according to a new report by Reports and Data. Interventional cardiology can be defined as a branch of cardiology that focuses specifically on the treatment of structural heart diseases, based on catheters. It is contrary to noninvasive or preventive treatments such as lifestyle changes and most imaging techniques, wherein this method of treatment mainly deals with more invasive treatments, involving stenting and catheters. Previously open-heart surgery was considered as the only option for care users having narrowing aortic heart valve or at a high risk of aortic stenosis. The fact that this form of cardiovascular treatment is a non-surgical option has resulted in its growing popularity, which in turn is boosting the demand for interventional cardiology devices. Furthermore, growing geriatric population and developments in interventional cardiology devices are some of the factors further propelling the growth of the market.

In context to region, Europe can be seen to occupy a prominent market share. The increasing occurrence rate of lifestyle diseases, continuous growth in the geriatric population, and expansion of the healthcare sector are some of the factors supporting the growth of the market in this region.

Key companies profiled in the report include

Abbott, Terumo Medical Corporation, Medtronic Inc., Boston Scientific Corporation, B Braun Melsungen, Johnson Johnson, Ivascular, C. R. Bard, Terumo Corporation and Biotronik.

Get a sample of the report @ https://reportsanddata.com/sample-enquiry-form/2361

The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Interventional Cardiology Devices market.

The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.

Order this report @ https://reportsanddata.com/report-pricing/2361

The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.

The key geographical regions analyzed in the market report are:

• North America (U.S.A., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Interventional Cardiology Devices Market Segmentation based on Types:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

• Intravascular Ultrasound (IVUS) Catheters
• Stents
• PTCA Guidewires
• Balloon Inflation Device
• PTCA Balloons

End-user Outlook (Revenue, USD Billion; 2018-2028)

• Homecare Setting
• Hospital
• Ambulatory surgical centers
• Clinic
• Others

Interventional Cardiology Devices Market Segmentation based on Application:

Application Outlook (Revenue, USD Billion; 2018-2028)

• Coronary angioplasty
• Congenital heart defect correction
• Valvuloplasty
• Percutaneous valve repair
• Percutaneous valve replacement
• Coronary thrombectomy
• Others

To know more about the report @ https://reportsanddata.com/report-detail/interventional-cardiology-devices-market

Further key findings from the report suggest

• The Interventional Cardiology Devices market held a market share of USD 15.49 Billion in the year 2018 that is forecasted to grow at a rate of 7.1% during the forecast period.
• In context to Product Type, the Stents segment generated the highest revenue of USD 8.52 Billion in the year 2018, with a growth rate of 7.4% during the forecast period. The extensive application of the cardiology devices in angioplasty procedures, wherein it is applied in more than 70% of these procedures, contributes to the revenue generated by this segment. A combination of stenting and angioplasty helps in enhancing the quality of life, particularly when performed after a heart attack, also contributes to its high acceptance and recommendation among care service providers.
• In context to Application, the Coronary angioplasty segment can be seen to generate the highest revenue of USD 4.34 Billion in 2018, with a growth rate of 7.3% during the forecast period. The high incidence rate of coronary artery diseases and applicability of angioplasty and associated devices in the treatment of the condition contributes to the revenue generated by this segment.
• In context to End-user, the Hospital segment is dominating that generated the highest revenue of USD 8.67 Billion in 2018, with a CAGR of 7.2% during the forecast period. The revenue generated by the segment is resultant of an increasing rate of hospitalization associated with cardiovascular diseases and elevated demand for interventional cardiology devices for providing treatment to these care users in hospitals.
• In regards to the region, Asia Pacific is projected to witness the fastest growth rate of 8.1% during the forecast, which is expected to hold 0% of the market by 2027. The growth rate witnessed by the region is resultant of developing healthcare infrastructure and increasing incidence rate of cardiovascular diseases in this region.

Request a customization on the report @ https://reportsanddata.com/request-customization-form/2361

Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.

Browse More Reports:

Neurostimulation Devices Market @ https://www.reportsanddata.com/report-detail/neurostimulation-devices-market

Infusion Therapy Market @ https://www.reportsanddata.com/report-detail/infusion-therapy-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:        

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com